Lifestyle
- Regular moderate exercise
- Adequate sleep
- Stress management
- Avoiding smoking
Lymphocytes · T-cells · B-cells
Lymphocyte count measures the number of lymphocytes in the blood, reflecting immune system activity.
Reference ranges may vary slightly by age and laboratory standards.
Lymphocytes, abbreviated as LYMPH, are a type of white blood cell pivotal to the immune system, primarily involved in the body's adaptive immune response. They include T-cells, B-cells, and natural killer cells, each playing distinct roles in pathogen recognition and elimination. Researchers have found that lymphocytes are critical in identifying and responding to foreign antigens, thus maintaining immune surveillance and homeostasis. Clinically, lymphocyte levels are significant indicators of immune function and can reflect various conditions. Elevated lymphocyte counts, or lymphocytosis, may indicate infections, certain cancers like lymphocytic leukemia, or autoimmune disorders. Conversely, low levels, or lymphocytopenia, can suggest immunodeficiency, bone marrow suppression, or chronic diseases. In the context of athletic performance and biohacking, lymphocyte levels can be indicative of immune system robustness, with potential implications for recovery and susceptibility to infections. However, researchers observed that factors such as stress, intense physical activity, and circadian rhythms can influence lymphocyte counts, necessitating careful interpretation of results. Time-of-day variations and fasting status may also affect measurements, as lymphocyte levels can fluctuate throughout the day and in response to dietary intake.
Klinische Bedeutung
Elevated lymphocyte levels can indicate infections, autoimmune disorders, or hematologic malignancies. Reduced levels may suggest immunodeficiency, bone marrow disorders, or chronic illness.
Progressively rising lymphocyte counts may suggest an ongoing immune response or lymphoproliferative disorder. Re-test in 4 weeks if abnormal.
Falling lymphocyte counts could indicate immunosuppression or bone marrow dysfunction.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting new supplements, especially if you have underlying health conditions.
Lymphocyte counts can vary with circadian rhythms; morning measurements are often preferred.
Testing Frequency
Annually for routine health check-ups, more frequently if monitoring a specific condition.
May affect
Current research suggests that the optimal strategies for quantifying tumour-infiltrating lymphocytes (TILs) and understanding the specific roles of different TIL subpopulations remain debated, with a lack of standardized approaches. Researchers have not yet established the functional profiles, spatial distributions, and clonal diversity of TILs in various treatment contexts. Additionally, clinical questions regarding the predictive value of circulating neoantigen-specific lymphocytes and their relationship to tumor-resident lymphocytes remain unanswered.
1,269
Total Citations
8
Human/RCT
4.9
Avg. Influence
2022
Latest
Researchers found that PD-1 expression on peripheral blood lymphocytes can identify neoantigen-specific T cells in melanoma patients. The study demonstrated that circulating CD8(+)PD-1(+) lymphocytes can target unique patient-specific neoantigens, suggesting a noninvasive method for developing personalized cancer therapies.
This study reviewed the role of T cells in cancer immunotherapy, focusing on their potential to target tumors. Researchers observed that various immunotherapy strategies aim to enhance T cell-mediated anti-tumor responses, indicating their clinical significance.
This study examined the role of tumour-infiltrating lymphocytes (TILs) in cancer immunotherapy. Researchers found that TILs are crucial for immune-mediated tumour elimination and highlighted the need for standardized quantification strategies to better understand their biological properties and clinical implications.
This study focused on exosomal PD-L1 in cancer, revealing its role in immunosuppression by inhibiting T cells. Researchers discussed the potential of exosomal PD-L1 as a tumor biomarker and its significance in immunotherapy.
This study explored the mechanisms behind drug-induced lupus, which is associated with the accumulation of autoreactive lymphocytes. Researchers observed that oxidative metabolites of drugs may trigger autoimmunity, highlighting the role of lymphocytes in this condition.
Researchers identified dysfunctional CD16+ CD8 T cells in smokers using single-cell analyses. They found that smoking is associated with an increase in differentiated T cells and a decrease in naïve T cells, indicating immune aging. This study suggests that smoking may lead to immune dysregulation, impacting overall health.
Researchers studied autoimmune lymphoproliferative syndrome (ALPS) and found that it involves abnormal accumulation of lymphocytes and autoimmunity. The study emphasized the need for targeted therapies and further investigation into the underlying molecular mechanisms.
This study analyzed the T-cell receptor (TCR) repertoire in hepatocellular carcinoma (HCC) patients. Researchers observed that peripheral blood TCR diversity is higher than that in tumor tissues, suggesting the potential of TCR sequences as non-invasive diagnostic biomarkers for HCC.
Researchers reviewed nonmalignant disorders of lymphocytes, noting that both lymphocytosis and lymphocytopenia can indicate various health conditions. The study highlighted the clinical laboratory's role in differentiating between reactive and malignant lymphoproliferative processes.
Researchers examined the dynamics of intestinal intraepithelial lymphocytes (IELs) and their role in immune defense against pathogens. The study indicated that IELs are involved in gut disorders, emphasizing their clinical significance and the need for further understanding of their functions.
Research publications about Lymphozyten over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer